  - Firms enter muscle treatment collaboration worth up to $490M
Astellas Pharma and Cytokinetics agreed to collaborate in the discovery, development and marketing of skeletal muscle activators for treatment of diseases and conditions related to muscle weakness. The deal also grants Astellas exclusive rights to jointly develop and market Cytokinetics' early-stage drug candidate CK-2127107, a skeletal troponin activator, for potential nonneuromuscular indications. Cytokinetics is eligible to receive more than $40 million in upfront payments and research funding, as well as more than $450 million in milestone fees as well as royalties. PharmaTimes (U.K.) (6/26), Genetic Engineering & Biotechnology News (6/25)        | Earn your MBA online from Northeastern University
Earn your MBA from an AACSB-accredited university that was one of the first to offer its MBA in an online format. Customize your MBA - pursue one of 8 specializations: Finance, Healthcare Management, High Technology Management, Innovation Entrepreneurship, International Management, Marketing, Operations & Supply Chain Management, or Sustainability.
Get started>> |
 - FDA OKs sepsis panel from BioFire Diagnostics
BioFire Diagnostics has secured FDA clearance for its FilmArray Blood Culture Identification, or BCID, panel, which the company says can detect more than 100 pathogens linked to sepsis. The device takes just about an hour to spot a pathogen in nine of 10 positive blood cultures and is meant to give hospitals a faster way to detect bloodstream infections. GenomeWeb Daily News (free registration) (6/25) - Coalition calls for improved reimbursement during CMS pricing review
Clinical lab organizations and companies that specialize in molecular diagnostics have formed the Coalition to Strengthen the Future of Molecular Diagnostics. The coalition is seeking an improvement in reimbursement rates while CMS is restructuring its pricing plans. The method being used now by CMS has resulted in reductions in payment rates of around 20% for many tests and as much as 80% for some tests compared with last year's rates. GenomeWeb Daily News (free registration) (6/24)  | Analyst brief: Axendia: Lowering the Cost of Healthcare from the Inside Out
Healthcare administrators are seeking ways to manage a mix of Clinical, Biomedical, Facilities, Engineering and Health IT assets. Learn how Healthcare Executives are leveraging an integrated Enterprise Asset Management solution to enhance patient care and improve clinical outcomes, reduce costs and ensure compliance. |
 | Company & Financial News |  |  | | | Industry Deals | | | | | Food & Agriculture | | | | | Industrial & Environmental | | | | - Calif. firm sees biofuel potential in energy beets
California-based Mendota Bioenergy is using a $5 million state grant to construct a demonstration-scale facility that would convert energy beets to ethanol, including some cellulosic ethanol. The beets have a superior output rate to sugar cane and corn, said Jim Tischer, a project manager for Mendota. "This is an excellent re-establishment of an old crop to a new end, to make advanced biofuels," he said. EthanolProducer.com (6/26)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| News from BIO | | | | - Secure document sharing services optimized for life science organizations
ShareVault, a leading provider of highly secure and controlled document sharing solutions and virtual data rooms (VDR), has aligned with BIO to provide companies with significant discounted pricing and complimentary extra features. ShareVault's VDR platform is optimized for life science companies of all sizes and flexibly priced so that even small biotech companies can afford and benefit from its technology. The ShareVault solution is intended for due diligence required during bio-pharma partnering, licensing, fundraising, M&A, clinical study management or other applications that require secure sharing of documents with third parties. Learn more and sign up for a free trial.
| SmartQuote | | | |  | One does not become a guru by accident."
--James Fenton,
British poet and journalist  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Wednesday, June 26, 2013
- Tuesday, June 25, 2013
- Monday, June 24, 2013
- Friday, June 21, 2013
- Thursday, June 20, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment